Victory Capital Management Inc. Has $11.11 Million Holdings in Express Scripts Holding (ESRX)

Victory Capital Management Inc. boosted its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 320.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 148,894 shares of the company’s stock after buying an additional 113,473 shares during the period. Victory Capital Management Inc.’s holdings in Express Scripts were worth $11,114,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Stonebridge Capital Advisors LLC lifted its holdings in Express Scripts by 0.4% during the second quarter. Stonebridge Capital Advisors LLC now owns 24,059 shares of the company’s stock worth $1,536,000 after buying an additional 100 shares during the period. National Asset Management Inc. lifted its holdings in Express Scripts by 1.5% during the second quarter. National Asset Management Inc. now owns 7,939 shares of the company’s stock worth $510,000 after buying an additional 115 shares during the period. Psagot Investment House Ltd. lifted its holdings in Express Scripts by 1.2% during the second quarter. Psagot Investment House Ltd. now owns 27,528 shares of the company’s stock worth $1,757,000 after buying an additional 327 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its holdings in Express Scripts by 2.4% during the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 16,565 shares of the company’s stock worth $1,071,000 after buying an additional 387 shares during the period. Finally, James Investment Research Inc. lifted its holdings in Express Scripts by 2.2% during the fourth quarter. James Investment Research Inc. now owns 30,241 shares of the company’s stock worth $2,257,000 after buying an additional 656 shares during the period. Institutional investors own 87.46% of the company’s stock.

Express Scripts Holding (NASDAQ:ESRX) opened at $74.93 on Thursday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $83.49. The stock has a market capitalization of $41,680.00, a price-to-earnings ratio of 12.45, a P/E/G ratio of 0.78 and a beta of 0.93.

Express Scripts declared that its board has initiated a stock repurchase plan on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

In related news, VP Glen D. Stettin sold 3,449 shares of the company’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the transaction, the vice president now directly owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Christine Houston sold 10,104 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the transaction, the vice president now directly owns 87,400 shares in the company, valued at $6,124,992. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,001 shares of company stock worth $1,249,505. 0.68% of the stock is owned by insiders.

ESRX has been the subject of a number of analyst reports. SunTrust Banks restated a “buy” rating and set a $95.00 target price on shares of Express Scripts in a report on Friday, January 12th. Robert W. Baird upgraded Express Scripts from a “neutral” rating to an “outperform” rating and upped their target price for the stock from $72.00 to $81.00 in a report on Friday, December 15th. Raymond James Financial restated a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Needham & Company LLC reiterated a “hold” rating on shares of Express Scripts in a report on Thursday, December 21st. Finally, Mizuho set a $67.00 price objective on Express Scripts and gave the company a “hold” rating in a report on Tuesday, October 24th. Five analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $79.29.

WARNING: This story was first posted by Week Herald and is the property of of Week Herald. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://weekherald.com/2018/02/15/victory-capital-management-inc-has-11-11-million-holdings-in-express-scripts-holding-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply